6/21/2021  5:31:31 PM Chg. -0.10 Volume Bid6:40:00 PM Ask6:40:00 PM Market Capitalization Dividend Y. P/E Ratio
65.25CHF -0.15% 126,392
Turnover: 8.25 mill.
-Bid Size: 1,530 65.80Ask Size: 208 3.23 bill.CHF 2.76% 18.75

Business description

Galenica AG is the leading fully integrated healthcare provider in Switzerland. With nearly 500 own, joint venture and independent partner pharmacies, Galenica operates the largest network of pharmacies in Switzerland. In addition, Galenica further develops and offers well-known own brands and prod-ucts, exclusive brands and products from business partners as well as a variety of on-site health services and tests for customers. Galenica is also the leading provider of pre-wholesale and whole-sale distribution as well as database services in the Swiss healthcare market.
 

Management board & Supervisory board

CEO
Marc Werner
Management board
Felix Burkhard, Andreas Koch, Daniele Madonna, Thomas Szuran, Virginie Pache
Supervisory board
Bertrand Jungo, Daniela Bosshardt, Dr. Andreas Walde, Dr. Markus R. Neuhaus, Dr. Philippe Nussbaumer, Pascale Bruderer, Prof. Dr. Michel Burnier
 

Company data

Name: Galenica AG
Address: Untermattweg 8,CH-3027 Bern
Phone: +41-58-8528111
Fax: +41-58-8528112
E-mail: info@galenica.com
Internet: www.galenica.com
Industry: Consumer Goods
Sector: Retailers
Sub sector: -
End of financial year: 12/31
Free Float: -
IPO date: 4/7/2017

Investor relations

Name: Felix Burkhard
IR phone: +41-58-8528529
IR Fax: +41-58-8528535
IR e-mail: investors@galenica.com

Company calendar

CW 32 | 8/3/2021 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Freefloat
 
78.30%
UBS Fund Management (Switzerland) AG, Switzerland
 
5.30%
Alecta Pensionsförsäkring, Sweden
 
4.00%
Credit Suisse Funds AG, Switzerland
 
3.30%
BlackRock, Inc., USA
 
3.10%
Rudolf Maag, Switzerland
 
3.00%
Norges Bank (Central Bank of Norway), Norway
 
3.00%
Others
 
0.00%